Non-Invasive Prenatal Testing Market was valued at US$ 2.41 Bn in 2021 and is expected to reach US$ 8.37 Bn by 2029, at a CAGR of 16.81 % during a forecast period. The report includes an analysis of the impact of COVID-19 lockdown on the revenue of market leaders, followers, and disruptors. Since the lockdown was implemented differently in various regions and countries; the impact of the same is also seen differently by regions and segments. The report has covered the current short-term and long-term impact on the market, and it would help the decision-makers to prepare the outline and strategies for companies by region.To know about the Research Methodology :- Request Free Sample Report
Non-Invasive Prenatal Testing Market Dynamics:
Non-invasive prenatal testing (NIPT) is a new genetic broadcast technique based on the analysis of cell-free incurable DNA in the maternal plasma. The market for non-invasive prenatal testing is growing knowingly over global, due to rise in occurrences of chromosomal aneuploidies among fetus, growing demand for initial, non-invasive screening procedures, and increase in progressive maternal age (earlier 23 to 26 years has increased to 30 years) which led to increase the growth of market share during the forecast period. Healthcare expenditure is growing worldwide, owing to the increasing prevalence of diseases and the innovation of new medical treatments. According to Research, the total healthcare expenditure is growing globally, which leads to the development of the healthcare infrastructure. This rise in healthcare expenditure leads to an increase in affordability & convenience of the new test and treatment for various conditions, which is projected to support the growth of the non-invasive prenatal testing market during the forecast period. On the other hand, there have been some expansions in diagnostic and medical science. Despite these developments, the NIPT market is undergoing some growth restraints, such as harsh regulations forced by governments in various countries. Hence, controlling guidelines and moral issues are significant factors that are projected to restraint the global Non-invasive prenatal testing market during the forecast period. However, to continue operating in the industry, the producers are essential to produce devices that follow standards of medical device affiliation. This regulatory development consumes too much time for approval of medical devices, which is hampering the rapid innovation and development of the devices. Therefore, strict government norms are acting as a barrier to the non-invasive prenatal testing market.Non-Invasive Prenatal Testing Market Segment Analysis:
On the basis of the application segment, the trisomy segment is projected to expand at a notable CAGR (XX %) during the forecast period. Moreover, Down’s syndrome is measured to be a common chromosomal disorder in the U.S. Growing new cases of Down’s syndrome among live births in the U.S. is an important factor accredited to the notable share held by the trisomy segment of the global non-invasive prenatal testing market in 2021.Non-Invasive Prenatal Testing Market Regional Insights:
North America is expected to increase the global non-invasive prenatal testing market, owing to the growing average maternal age, increasing healthcare expenditure, growing demand for the initial and non-invasive procedures, and increasing prevalence of chromosome syndromes in the region. Among the North American countries, the U.S. leads to the NIPT market in North America and it is expected to hold a market share of over 80% by 2021. It is also anticipated to be the fastest-growing market for NIPT in the region during the forecast period. The objective of the report is to present comprehensive assessment projections with a suitable set of assumptions and methodology. The report helps in understanding Global Non-Invasive Prenatal Testing market dynamics, structure by identifying and analyzing the market segments and projecting the global market size. Further, the report also focuses on the competitive analysis of key players by product, price, financial position, growth strategies, and regional presence. To understand the market dynamics and by region, the report has covered the PEST analysis by region and key economies across the globe, which are supposed to have an impact on the market in the forecast period. PORTER’s analysis, and SVOR analysis of the market as well as detailed SWOT analysis of key players has been done to analyze their strategies. The report will to address all questions of shareholders to prioritize the efforts and investment in the near future to the emerging segment in the Global Non-Invasive Prenatal Testing market.Non-Invasive Prenatal Testing market, Key Highlights:
• Global Non-Invasive Prenatal Testing market analysis and forecast, in terms of value. • Comprehensive study and analysis of market drivers, restraints and opportunities influencing the growth of the Global Non-Invasive Prenatal Testing market • Global Non-Invasive Prenatal Testing market segmentation on the basis of type, source, end-user, and region (country-wise) has been provided. • Global Non-Invasive Prenatal Testing market strategic analysis with respect to individual growth trends, future prospects along with the contribution of various sub-market stakeholders have been considered under the scope of study. • Global Non-Invasive Prenatal Testing market analysis and forecast for five major regions namely North America, Europe, Asia Pacific, the Middle East & Africa (MEA) and Latin America along with country-wise segmentation. • Profiles of key industry players, their strategic perspective, market positioning and analysis of core competencies are further profiled. • Competitive developments, investments, strategic expansion and competitive landscape of the key players operating in the Global Non-Invasive Prenatal Testing market are also profiled.Non-Invasive Prenatal Testing Market Scope: Inquire before buying
Non-Invasive Prenatal Testing Market, by Test Type
• Materni21 • Harmony • Panorama • Verify • NIFTY • OthersNon-Invasive Prenatal Testing Market, by Application
• Trisomy • Micro deletions Symptoms • OthersNon-Invasive Prenatal Testing Market, by Technology
• NGS • WGS • OthersNon-Invasive Prenatal Testing Market, by End-User
• Hospitals • Diagnostic Laboratories • OthersNon-Invasive Prenatal Testing Market, by Region
• North America • Europe • Asia Pacific • Middle East & Africa • South AmericaNon-Invasive Prenatal Testing Market Key Player
• Berry Genetics • BGI • Laboratory Corporation of America Holdings • Agilent Technologies, Inc. • Illumina, Inc • Hoffmann-La Roche Ltd • NATERA, INC. • PerkinElmer Inc • Eurofins LifeCodexx AG • IGENOMIX. • Thermo Fisher Scientific Inc. • GE Healthcare • Yourgene Health • Genesis Genetics • Centogene N.V. • MedGenome Labs Ltd. • Myriad Women’s Health, Inc. • Progenity, Inc. • Qiagen • Quest Diagnostics, Inc. Frequently Asked Questions: 1. Which region has the largest share in Global Non-Invasive Prenatal Testing Market? Ans: North America region holds the highest share in 2021. 2. What is the growth rate of Global Non-Invasive Prenatal Testing Market? Ans: The Global Non-Invasive Prenatal Testing Market is growing at a CAGR of 16.81% during forecasting period 2022-2029. 3. What is scope of the Global Non-Invasive Prenatal Testing market report? Ans: Global Non-Invasive Prenatal Testing Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period. 4. Who are the key players in Global Non-Invasive Prenatal Testing market? Ans: The important key players in the Global Non-Invasive Prenatal Testing Market are – Berry Genetics, BGI, Laboratory Corporation of America Holdings, Agilent Technologies, Inc., Illumina, Inc, Hoffmann-La Roche Ltd, NATERA, INC., PerkinElmer Inc, Eurofins LifeCodexx AG, IGENOMIX., Thermo Fisher Scientific Inc., GE Healthcare, Yourgene Health, Genesis Genetics, Centogene N.V., MedGenome Labs Ltd., Myriad Women’s Health, Inc., Progenity, Inc., Qiagen, Quest Diagnostics, and Inc. 5. What is the study period of this market? Ans: The Global Non-Invasive Prenatal Testing Market is studied from 2021 to 2029.
Global Non-Invasive Prenatal Testing Market
1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Non-Invasive Prenatal Testing Market, by Market Value (US$ Bn) 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7. Industry Trends in Global Non-Invasive Prenatal Testing Market 4.8. Global Non-Invasive Prenatal Testing Market Competitive Landscape 5. Supply Side and Demand Side Indicators 6. Global Non-Invasive Prenatal Testing Market Analysis and Forecast 6.1. Global Non-Invasive Prenatal Testing Market Size & Y-o-Y Growth Analysis 6.1.1. North America 6.1.2. Europe 6.1.3. Asia Pacific 6.1.4. Middle East & Africa 6.1.5. South America 7. Global Non-Invasive Prenatal Testing Market Analysis and Forecast, by Test Type 7.1. Introduction and Definition 7.2. Key Findings 7.3. Global Non-Invasive Prenatal Testing Market Value Share Analysis, by Test Type 7.4. Global Non-Invasive Prenatal Testing Market Size (US$ Bn) Forecast, by Test Type 7.5. Global Non-Invasive Prenatal Testing Market Analysis, by Test Type 7.6. Global Non-Invasive Prenatal Testing Market Attractiveness Analysis, by Test Type 8. Global Non-Invasive Prenatal Testing Market Analysis and Forecast, by Technology 8.1. Introduction and Definition 8.2. Key Findings 8.3. Global Non-Invasive Prenatal Testing Market Value Share Analysis, by Technology 8.4. Global Non-Invasive Prenatal Testing Market Size (US$ Bn) Forecast, by Technology 8.5. Global Non-Invasive Prenatal Testing Market Analysis, by Technology 8.6. Global Non-Invasive Prenatal Testing Market Attractiveness Analysis, by Technology 9. Global Non-Invasive Prenatal Testing Market Analysis and Forecast, by Application 9.1. Introduction and Definition 9.2. Key Findings 9.3. Global Non-Invasive Prenatal Testing Market Value Share Analysis, by Application 9.4. Global Non-Invasive Prenatal Testing Market Size (US$ Bn) Forecast, by Application 9.5. Global Non-Invasive Prenatal Testing Market Analysis, by Application 9.6. Global Non-Invasive Prenatal Testing Market Attractiveness Analysis, by Application 10. Global Non-Invasive Prenatal Testing Market Analysis and Forecast, by End-User 10.1. Introduction and Definition 10.2. Key Findings 10.3. Global Non-Invasive Prenatal Testing Market Value Share Analysis, by End-User 10.4. Global Non-Invasive Prenatal Testing Market Size (US$ Bn) Forecast, by End-User 10.5. Global Non-Invasive Prenatal Testing Market Analysis, by End-User 10.6. Global Non-Invasive Prenatal Testing Market Attractiveness Analysis, by End-User 11. Global Non-Invasive Prenatal Testing Market Analysis, by Region 11.1. Global Non-Invasive Prenatal Testing Market Value Share Analysis, by Region 11.2. Global Non-Invasive Prenatal Testing Market Size (US$ Bn) Forecast, by Region 11.3. Global Non-Invasive Prenatal Testing Market Attractiveness Analysis, by Region 12. North America Non-Invasive Prenatal Testing Market Analysis 12.1. Key Findings 12.2. North America Non-Invasive Prenatal Testing Market Overview 12.3. North America Non-Invasive Prenatal Testing Market Value Share Analysis, by Test Type 12.4. North America Non-Invasive Prenatal Testing Market Forecast, by Test Type 12.4.1. Materni21 12.4.2. Harmony 12.4.3. Panorama 12.4.4. Verify 12.4.5. NIFTY 12.4.6. Others 12.5. North America Non-Invasive Prenatal Testing Market Value Share Analysis, by Technology 12.6. North America Non-Invasive Prenatal Testing Market Forecast, by Technology 12.6.1. NGS 12.6.2. WGS 12.6.3. Others 12.7. North America Non-Invasive Prenatal Testing Market Value Share Analysis, by Application 12.8. North America Non-Invasive Prenatal Testing Market Forecast, by Application 12.8.1. Trisomy 12.8.2. Micro deletions Symptoms 12.8.3. Others 12.9. North America Non-Invasive Prenatal Testing Market Value Share Analysis, by End-User 12.10. North America Non-Invasive Prenatal Testing Market Forecast, by End-User 12.10.1. Hospitals 12.10.2. Diagnostic Laboratories 12.10.3. Others 12.11. North America Non-Invasive Prenatal Testing Market Value Share Analysis, by Country 12.12. North America Non-Invasive Prenatal Testing Market Forecast, by Country 12.12.1. U.S. 12.12.2. Canada 12.13. North America Non-Invasive Prenatal Testing Market Analysis, by Country 12.14. U.S. Non-Invasive Prenatal Testing Market Forecast, by Test Type 12.14.1. Materni21 12.14.2. Harmony 12.14.3. Panorama 12.14.4. Verify 12.14.5. NIFTY 12.14.6. Others 12.15. U.S. Non-Invasive Prenatal Testing Market Forecast, by Technology 12.15.1. NGS 12.15.2. WGS 12.15.3. Others 12.16. U.S. Non-Invasive Prenatal Testing Market Forecast, by Application 12.16.1. Trisomy 12.16.2. Micro deletions Symptoms 12.16.3. Others 12.17. U.S. Non-Invasive Prenatal Testing Market Forecast, by End-User 12.17.1. Hospitals 12.17.2. Diagnostic Laboratories 12.17.3. Others 12.18. Canada Non-Invasive Prenatal Testing Market Forecast, by Test Type 12.18.1. Materni21 12.18.2. Harmony 12.18.3. Panorama 12.18.4. Verify 12.18.5. NIFTY 12.18.6. Others 12.19. Canada Non-Invasive Prenatal Testing Market Forecast, by Technology 12.19.1. NGS 12.19.2. WGS 12.19.3. Others 12.20. Canada Non-Invasive Prenatal Testing Market Forecast, by Application 12.20.1. Trisomy 12.20.2. Micro deletions Symptoms 12.20.3. Others 12.21. Canada Non-Invasive Prenatal Testing Market Forecast, by End-User 12.21.1. Hospitals 12.21.2. Diagnostic Laboratories 12.21.3. Others 12.22. North America Non-Invasive Prenatal Testing Market Attractiveness Analysis 12.22.1. By Test Type 12.22.2. By Technology 12.22.3. By Application 12.22.4. By End-User 12.23. PEST Analysis 12.24. Key Trends 12.25. Key Development 13. Europe Non-Invasive Prenatal Testing Market Analysis 13.1. Key Findings 13.2. Europe Non-Invasive Prenatal Testing Market Overview 13.3. Europe Non-Invasive Prenatal Testing Market Value Share Analysis, by Test Type 13.4. Europe Non-Invasive Prenatal Testing Market Forecast, by Test Type 13.4.1. Materni21 13.4.2. Harmony 13.4.3. Panorama 13.4.4. Verify 13.4.5. NIFTY 13.4.6. Others 13.5. Europe Non-Invasive Prenatal Testing Market Value Share Analysis, by Technology 13.6. Europe Non-Invasive Prenatal Testing Market Forecast, by Technology 13.6.1. NGS 13.6.2. WGS 13.6.3. Others 13.7. Europe Non-Invasive Prenatal Testing Market Value Share Analysis, by Application 13.8. Europe Non-Invasive Prenatal Testing Market Forecast, by Application 13.8.1. Trisomy 13.8.2. Micro deletions Symptoms 13.8.3. Others 13.9. Europe Non-Invasive Prenatal Testing Market Value Share Analysis, by End-User 13.10. Europe Non-Invasive Prenatal Testing Market Forecast, by End-User 13.10.1. Hospitals 13.10.2. Diagnostic Laboratories 13.10.3. Others 13.11. Others Europe Non-Invasive Prenatal Testing Market Value Share Analysis, by Country 13.12. Europe Non-Invasive Prenatal Testing Market Forecast, by Country 13.12.1. Germany 13.12.2. U.K. 13.12.3. France 13.12.4. Italy 13.12.5. Spain 13.12.6. Rest of Europe 13.13. Europe Non-Invasive Prenatal Testing Market Analysis, by Country 13.14. Germany Non-Invasive Prenatal Testing Market Forecast, by Test Type 13.14.1. Materni21 13.14.2. Harmony 13.14.3. Panorama 13.14.4. Verify 13.14.5. NIFTY 13.14.6. Others 13.15. Germany Non-Invasive Prenatal Testing Market Forecast, by Technology 13.15.1. NGS 13.15.2. WGS 13.15.3. Others 13.16. Germany Non-Invasive Prenatal Testing Market Forecast, by Application 13.16.1. Trisomy 13.16.2. Micro deletions Symptoms 13.16.3. Others 13.17. Germany Non-Invasive Prenatal Testing Market Forecast, by End-User 13.17.1. Hospitals 13.17.2. Diagnostic Laboratories 13.17.3. Others 13.18. U.K. Non-Invasive Prenatal Testing Market Forecast, by Test Type 13.18.1. Materni21 13.18.2. Harmony 13.18.3. Panorama 13.18.4. Verify 13.18.5. NIFTY 13.18.6. Others 13.19. U.K. Non-Invasive Prenatal Testing Market Forecast, by Technology 13.19.1. NGS 13.19.2. WGS 13.19.3. Others 13.20. U.K. Non-Invasive Prenatal Testing Market Forecast, by Application 13.20.1. Trisomy 13.20.2. Micro deletions Symptoms 13.20.3. Others 13.21. U.K. Non-Invasive Prenatal Testing Market Forecast, by End-User 13.21.1. Hospitals 13.21.2. Diagnostic Laboratories 13.21.3. Others 13.22. France Non-Invasive Prenatal Testing Market Forecast, by Test Type 13.22.1. Materni21 13.22.2. Harmony 13.22.3. Panorama 13.22.4. Verify 13.22.5. NIFTY 13.22.6. Others 13.23. France Non-Invasive Prenatal Testing Market Forecast, by Technology 13.23.1. NGS 13.23.2. WGS 13.23.3. Others 13.24. France Non-Invasive Prenatal Testing Market Forecast, by Application 13.24.1. Trisomy 13.24.2. Micro deletions Symptoms 13.24.3. Others 13.25. France Non-Invasive Prenatal Testing Market Forecast, by End-User 13.25.1. Hospitals 13.25.2. Diagnostic Laboratories 13.25.3. Others 13.26. Italy Non-Invasive Prenatal Testing Market Forecast, by Test Type 13.26.1. Materni21 13.26.2. Harmony 13.26.3. Panorama 13.26.4. Verify 13.26.5. NIFTY 13.26.6. Others 13.27. Italy Non-Invasive Prenatal Testing Market Forecast, by Technology 13.27.1. NGS 13.27.2. WGS 13.27.3. Others 13.28. Italy Non-Invasive Prenatal Testing Market Forecast, by Application 13.28.1. Trisomy 13.28.2. Micro deletions Symptoms 13.28.3. Others 13.29. Italy Non-Invasive Prenatal Testing Market Forecast, by End-User 13.29.1. Hospitals 13.29.2. Diagnostic Laboratories 13.29.3. Others 13.30. Spain Non-Invasive Prenatal Testing Market Forecast, by Test Type 13.30.1. Materni21 13.30.2. Harmony 13.30.3. Panorama 13.30.4. Verify 13.30.5. NIFTY 13.30.6. Others 13.31. Spain Non-Invasive Prenatal Testing Market Forecast, by Technology 13.31.1. NGS 13.31.2. WGS 13.31.3. Others 13.32. Spain Non-Invasive Prenatal Testing Market Forecast, by Application 13.32.1. Trisomy 13.32.2. Micro deletions Symptoms 13.32.3. Others 13.33. Spain Non-Invasive Prenatal Testing Market Forecast, by End-User 13.33.1. Hospitals 13.33.2. Diagnostic Laboratories 13.33.3. Others 13.34. Rest of Europe Non-Invasive Prenatal Testing Market Forecast, by Test Type 13.34.1. Materni21 13.34.2. Harmony 13.34.3. Panorama 13.34.4. Verify 13.34.5. NIFTY 13.34.6. Others 13.35. Rest of Europe Non-Invasive Prenatal Testing Market Forecast, by Technology 13.35.1. NGS 13.35.2. WGS 13.35.3. Others 13.36. Rest of Europe Non-Invasive Prenatal Testing Market Forecast, by Application 13.36.1. Trisomy 13.36.2. Micro deletions Symptoms 13.36.3. Others 13.37. Rest Of Europe Non-Invasive Prenatal Testing Market Forecast, by End-User 13.37.1. Hospitals 13.37.2. Diagnostic Laboratories 13.37.3. Others 13.38. Europe Non-Invasive Prenatal Testing Market Attractiveness Analysis 13.38.1. By Test Type 13.38.2. By Technology 13.38.3. By Application 13.38.4. By End-User 13.39. PEST Analysis 13.40. Key Trends 13.41. Key Development 14. Asia Pacific Non-Invasive Prenatal Testing Market Analysis 14.1. Key Findings 14.2. Asia Pacific Non-Invasive Prenatal Testing Market Overview 14.3. Asia Pacific Non-Invasive Prenatal Testing Market Value Share Analysis, by Test Type 14.4. Asia Pacific Non-Invasive Prenatal Testing Market Forecast, by Test Type 14.4.1. Materni21 14.4.2. Harmony 14.4.3. Panorama 14.4.4. Verify 14.4.5. NIFTY 14.4.6. Others 14.5. Asia Pacific Non-Invasive Prenatal Testing Market Value Share Analysis, by Technology 14.6. Asia Pacific Non-Invasive Prenatal Testing Market Forecast, by Technology 14.6.1. NGS 14.6.2. WGS 14.6.3. Others 14.7. Asia Pacific Non-Invasive Prenatal Testing Market Value Share Analysis, by Application 14.8. Asia Pacific Non-Invasive Prenatal Testing Market Forecast, by Application 14.8.1. Trisomy 14.8.2. Micro deletions Symptoms 14.8.3. Others 14.9. Asia Pacific Non-Invasive Prenatal Testing Market Value Share Analysis, by End-User 14.10. Asia Pacific Non-Invasive Prenatal Testing Market Forecast, by End-User 14.10.1. Hospitals 14.10.2. Diagnostic Laboratories 14.10.3. Others 14.11. Asia Pacific Non-Invasive Prenatal Testing Market Value Share Analysis, by Country 14.12. Asia Pacific Non-Invasive Prenatal Testing Market Forecast, by Country 14.12.1. China 14.12.2. India 14.12.3. Japan 14.12.4. ASEAN 14.12.5. Rest of Asia Pacific 14.13. Asia Pacific Non-Invasive Prenatal Testing Market Analysis, by Country 14.14. China Non-Invasive Prenatal Testing Market Forecast, by Test Type 14.14.1. Materni21 14.14.2. Harmony 14.14.3. Panorama 14.14.4. Verify 14.14.5. NIFTY 14.14.6. Others 14.15. China Non-Invasive Prenatal Testing Market Forecast, by Technology 14.15.1. NGS 14.15.2. WGS 14.15.3. Others 14.16. China Non-Invasive Prenatal Testing Market Forecast, by Application 14.16.1. Trisomy 14.16.2. Micro deletions Symptoms 14.16.3. Others 14.17. China Non-Invasive Prenatal Testing Market Forecast, by End-User 14.17.1. Hospitals 14.17.2. Diagnostic Laboratories 14.17.3. Others 14.18. India Non-Invasive Prenatal Testing Market Forecast, by Test Type 14.18.1. Materni21 14.18.2. Harmony 14.18.3. Panorama 14.18.4. Verify 14.18.5. NIFTY 14.18.6. Others 14.19. India Non-Invasive Prenatal Testing Market Forecast, by Technology 14.19.1. NGS 14.19.2. WGS 14.19.3. Others 14.20. India Non-Invasive Prenatal Testing Market Forecast, by Application 14.20.1. Trisomy 14.20.2. Micro deletions Symptoms 14.20.3. Others 14.21. India Non-Invasive Prenatal Testing Market Forecast, by End-User 14.21.1. Hospitals 14.21.2. Diagnostic Laboratories 14.21.3. Others 14.22. Japan Non-Invasive Prenatal Testing Market Forecast, by Test Type 14.22.1. Materni21 14.22.2. Harmony 14.22.3. Panorama 14.22.4. Verify 14.22.5. NIFTY 14.22.6. Others 14.23. Japan Non-Invasive Prenatal Testing Market Forecast, by Technology 14.23.1. NGS 14.23.2. WGS 14.23.3. Others 14.24. Japan Non-Invasive Prenatal Testing Market Forecast, by Application 14.24.1. Trisomy 14.24.2. Micro deletions Symptoms 14.24.3. Others 14.25. Japan Non-Invasive Prenatal Testing Market Forecast, by End-User 14.25.1. Hospitals 14.25.2. Diagnostic Laboratories 14.25.3. Others 14.26. ASEAN Non-Invasive Prenatal Testing Market Forecast, by Test Type 14.26.1. Materni21 14.26.2. Harmony 14.26.3. Panorama 14.26.4. Verify 14.26.5. NIFTY 14.26.6. Others 14.27. ASEAN Non-Invasive Prenatal Testing Market Forecast, by Technology 14.27.1. NGS 14.27.2. WGS 14.27.3. Others 14.28. ASEAN Non-Invasive Prenatal Testing Market Forecast, by Application 14.28.1. Trisomy 14.28.2. Micro deletions Symptoms 14.28.3. Others 14.29. ASEAN Non-Invasive Prenatal Testing Market Forecast, by End-User 14.29.1. Hospitals 14.29.2. Diagnostic Laboratories 14.29.3. Others 14.30. Rest of Asia Pacific Non-Invasive Prenatal Testing Market Forecast, by Test Type 14.30.1. Materni21 14.30.2. Harmony 14.30.3. Panorama 14.30.4. Verify 14.30.5. NIFTY 14.30.6. Others 14.31. Rest of Asia Pacific Non-Invasive Prenatal Testing Market Forecast, by Technology 14.31.1. NGS 14.31.2. WGS 14.31.3. Others 14.32. Rest of Asia Pacific Non-Invasive Prenatal Testing Market Forecast, by Application 14.32.1. Trisomy 14.32.2. Micro deletions Symptoms 14.32.3. Others 14.33. Rest of Asia Pacific Non-Invasive Prenatal Testing Market Forecast, by End-User 14.33.1. Hospitals 14.33.2. Diagnostic Laboratories 14.33.3. Others 14.34. Asia Pacific Non-Invasive Prenatal Testing Market Attractiveness Analysis 14.34.1. By Test Type 14.34.2. By Technology 14.34.3. By Application 14.34.4. By End-User 14.35. PEST Analysis 14.36. Key Trends 14.37. Key Development 15. Middle East & Africa Non-Invasive Prenatal Testing Market Analysis 15.1. Key Findings 15.2. Middle East & Africa Non-Invasive Prenatal Testing Market Overview 15.3. Middle East & Africa Non-Invasive Prenatal Testing Market Value Share Analysis, by Test Type 15.4. Middle East & Africa Non-Invasive Prenatal Testing Market Forecast, by Test Type 15.4.1. Materni21 15.4.2. Harmony 15.4.3. Panorama 15.4.4. Verify 15.4.5. NIFTY 15.4.6. Others 15.5. Middle East & Africa Non-Invasive Prenatal Testing Market Value Share Analysis, by Technology 15.6. Middle East & Africa Non-Invasive Prenatal Testing Market Forecast, by Technology 15.6.1. NGS 15.6.2. WGS 15.6.3. Others 15.7. Middle East & Africa Non-Invasive Prenatal Testing Market Value Share Analysis, by Application 15.8. Middle East & Africa Non-Invasive Prenatal Testing Market Forecast, by Application 15.8.1. Trisomy 15.8.2. Micro deletions Symptoms 15.8.3. Others 15.9. Middle East & Africa Non-Invasive Prenatal Testing Market Value Share Analysis, by End-User 15.10. Middle East & Africa Non-Invasive Prenatal Testing Market Forecast, by End-User 15.10.1. Hospitals 15.10.2. Diagnostic Laboratories 15.10.3. Others 15.11. Middle East & Africa Non-Invasive Prenatal Testing Market Value Share Analysis, by Country 15.12. Middle East & Africa Non-Invasive Prenatal Testing Market Forecast, by Country 15.12.1. GCC 15.12.2. South Africa 15.12.3. Rest of Middle East & Africa 15.13. Middle East & Africa Non-Invasive Prenatal Testing Market Analysis, by Country 15.14. GCC Non-Invasive Prenatal Testing Market Forecast, by Test Type 15.14.1. Materni21 15.14.2. Harmony 15.14.3. Panorama 15.14.4. Verify 15.14.5. NIFTY 15.14.6. Others 15.15. GCC Non-Invasive Prenatal Testing Market Forecast, by Technology 15.15.1. NGS 15.15.2. WGS 15.15.3. Others 15.16. GCC Non-Invasive Prenatal Testing Market Forecast, by Application 15.16.1. Trisomy 15.16.2. Micro deletions Symptoms 15.16.3. Others 15.17. GCC Non-Invasive Prenatal Testing Market Forecast, by End-User 15.17.1. Hospitals 15.17.2. Diagnostic Laboratories 15.17.3. Others 15.18. South Africa Non-Invasive Prenatal Testing Market Forecast, by Test Type 15.18.1. Materni21 15.18.2. Harmony 15.18.3. Panorama 15.18.4. Verify 15.18.5. NIFTY 15.18.6. Others 15.19. South Africa Non-Invasive Prenatal Testing Market Forecast, by Technology 15.19.1. NGS 15.19.2. WGS 15.19.3. Others 15.20. South Africa Non-Invasive Prenatal Testing Market Forecast, by Application 15.20.1. Trisomy 15.20.2. Micro deletions Symptoms 15.20.3. Others 15.21. South Africa Non-Invasive Prenatal Testing Market Forecast, by End-User 15.21.1. Hospitals 15.21.2. Diagnostic Laboratories 15.21.3. Others 15.22. Rest of Middle East & Africa Non-Invasive Prenatal Testing Market Forecast, by Test Type 15.22.1. Materni21 15.22.2. Harmony 15.22.3. Panorama 15.22.4. Verify 15.22.5. NIFTY 15.22.6. Others 15.23. Rest of Middle East & Africa Non-Invasive Prenatal Testing Market Forecast, by Technology 15.23.1. NGS 15.23.2. WGS 15.23.3. Others 15.24. Rest of Middle East & Africa Non-Invasive Prenatal Testing Market Forecast, by Application 15.24.1. Trisomy 15.24.2. Micro deletions Symptoms 15.24.3. Others 15.25. Rest of Middle East & Africa Non-Invasive Prenatal Testing Market Forecast, by End-User 15.25.1. Hospitals 15.25.2. Diagnostic Laboratories 15.25.3. Others 15.26. Middle East & Africa Non-Invasive Prenatal Testing Market Attractiveness Analysis 15.26.1. By Test Type 15.26.2. By Technology 15.26.3. By Application 15.26.4. By End-User 15.27. PEST Analysis 15.28. Key Trends 15.29. Key Development 16. South America Non-Invasive Prenatal Testing Market Analysis 16.1. Key Findings 16.2. South America Non-Invasive Prenatal Testing Market Overview 16.3. South America Non-Invasive Prenatal Testing Market Value Share Analysis, by Test Type 16.4. South America Non-Invasive Prenatal Testing Market Forecast, by Test Type 16.4.1. Materni21 16.4.2. Harmony 16.4.3. Panorama 16.4.4. Verify 16.4.5. NIFTY 16.4.6. Others 16.5. South America Non-Invasive Prenatal Testing Market Value Share Analysis, by Technology 16.6. South America Non-Invasive Prenatal Testing Market Forecast, by Technology 16.6.1. NGS 16.6.2. WGS 16.6.3. Others 16.7. South America Non-Invasive Prenatal Testing Market Value Share Analysis, by Application 16.8. South America Non-Invasive Prenatal Testing Market Forecast, by Application 16.8.1. Trisomy 16.8.2. Micro deletions Symptoms 16.8.3. Others 16.9. South America Non-Invasive Prenatal Testing Market Value Share Analysis, by End-User 16.10. South America Non-Invasive Prenatal Testing Market Forecast, by End-User 16.10.1. Hospitals 16.10.2. Diagnostic Laboratories 16.10.3. Others 16.11. South America Non-Invasive Prenatal Testing Market Value Share Analysis, by Country 16.12. South America Non-Invasive Prenatal Testing Market Forecast, by Country 16.12.1. Brazil 16.12.2. Mexico 16.12.3. Rest of South America 16.13. South America Non-Invasive Prenatal Testing Market Analysis, by Country 16.14. Brazil Non-Invasive Prenatal Testing Market Forecast, by Test Type 16.14.1. Materni21 16.14.2. Harmony 16.14.3. Panorama 16.14.4. Verify 16.14.5. NIFTY 16.14.6. Others 16.15. Brazil Non-Invasive Prenatal Testing Market Forecast, by Technology 16.15.1. NGS 16.15.2. WGS 16.15.3. Others 16.16. Brazil Non-Invasive Prenatal Testing Market Forecast, by Application 16.16.1. Trisomy 16.16.2. Micro deletions Symptoms 16.16.3. Others 16.17. Brazil Non-Invasive Prenatal Testing Market Forecast, by End-User 16.17.1. Hospitals 16.17.2. Diagnostic Laboratories 16.17.3. Others 16.18. Mexico Non-Invasive Prenatal Testing Market Forecast, by Test Type 16.18.1. Materni21 16.18.2. Harmony 16.18.3. Panorama 16.18.4. Verify 16.18.5. NIFTY 16.18.6. Others 16.19. Mexico Non-Invasive Prenatal Testing Market Forecast, by Technology 16.19.1. NGS 16.19.2. WGS 16.19.3. Others 16.20. Mexico Non-Invasive Prenatal Testing Market Forecast, by Application 16.20.1. Trisomy 16.20.2. Micro deletions Symptoms 16.20.3. Others 16.21. Mexico Non-Invasive Prenatal Testing Market Forecast, by End-User 16.21.1. Hospitals 16.21.2. Diagnostic Laboratories 16.21.3. Others 16.22. Rest of South America Non-Invasive Prenatal Testing Market Forecast, by Test Type 16.22.1. Materni21 16.22.2. Harmony 16.22.3. Panorama 16.22.4. Verify 16.22.5. NIFTY 16.22.6. Others 16.23. Rest of South America Non-Invasive Prenatal Testing Market Forecast, by Technology 16.23.1. NGS 16.23.2. WGS 16.23.3. Others 16.24. Rest of South America Non-Invasive Prenatal Testing Market Forecast, by Application 16.24.1. Trisomy 16.24.2. Micro deletions Symptoms 16.24.3. Others 16.25. Rest of South America Non-Invasive Prenatal Testing Market Forecast, by End-User 16.25.1. Hospitals 16.25.2. Diagnostic Laboratories 16.25.3. Others 16.26. South America Non-Invasive Prenatal Testing Market Attractiveness Analysis 16.26.1. By Test Type 16.26.2. By Technology 16.26.3. By Application 16.26.4. By End-User 16.27. PEST Analysis 16.28. Key Trends 16.29. Key Development 17. Company Profiles 17.1. Market Share Analysis, by Company 17.2. Competition Matrix 17.2.1. Competitive Benchmarking of key players by price, presence, market share, Ingredients and R&D investment 17.2.2. New Asset Type Launches and Asset Type Enhancements 17.2.3. Market Consolidation 17.2.3.1. M&A by Regions, Investment and Ingredients 17.2.3.2. M&A Key Players, Forward Integration and Backward Integration 17.3. Company Profiles: Key Players 17.3.1. Berry Genetics 17.3.1.1. Company Overview 17.3.1.2. Financial Overview 17.3.1.3. Asset Type Portfolio 17.3.1.4. Business Strategy 17.3.1.5. Recent Developments 17.3.1.6. Company Footprint 17.3.2. BGI 17.3.3. Laboratory Corporation of America Holdings 17.3.4. Agilent Technologies, Inc. 17.3.5. Illumina, Inc 17.3.6. Hoffmann-La Roche Ltd 17.3.7. NATERA, INC. 17.3.8. PerkinElmer Inc 17.3.9. Eurofins LifeCodexx AG 17.3.10. IGENOMIX. 17.3.11. Thermo Fisher Scientific Inc. 17.3.12. GE Healthcare 17.3.13. Yourgene Health 17.3.14. Genesis Genetics 17.3.15. Centogene N.V. 17.3.16. MedGenome Labs Ltd. 17.3.17. Myriad Women’s Health, Inc. 17.3.18. Progenity, Inc. 17.3.19. Qiagen 17.3.20. Quest Diagnostics, Inc. 18. Primary Key Insights